ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Novo Nordisk A/s Complete list of announcements declared & dividend announcements by Novo Nordisk A/s NVO

Novo Nordisk A/s NVO listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Novo Nordisk A/s NVO

Beat the Market the Zacks Way: NVIDIA, Novo Nordisk, Matson in Focus
All three widely followed indexes closed a winning week last Friday. For Wall Street, it was a second straight week of gains. The Dow Jones Industrial Average, the S&P 500 and the Nasdaq Composite advanced 1.4%, 2.5% and 3.3%,
Announcement as on 05 September 2023

: Novo Nordisk obesity drug Wegovy eases symptoms of heart failure, study finds
The Novo Nordisk NVO obesity drug semaglutide, marketed as Wegovy, can significantly reduce symptoms related to heart failure, according to a study published Friday in the New England Journal of Medicine. On a questionnaire measuring the symptoms and physi
Announcement as on 25 August 2023

Novo Nordisk - ADR (NVO) Declares [CO].88 Dividend
Novo Nordisk - ADR said on August 10, 2023 that its board of directors declared a regular semi-annual dividend of [CO].88 per share (.77 annualized). Previously, the company paid .18 per share.
Announcement as on 18 August 2023

Novo Nordisk Soars To New High On Weight-Loss Drug Trial Results
Weight-loss drugs are the pharmaceutical industry’s equivalent of AI, in the sense of being a product with the capability to send shares soaring. Novo Nordisk A/S (NYSE: NVO), maker of Wegovy, saw its stock gap up more than 16% on August 8, after the
Announcement as on 09 August 2023

: Novo Nordisk says Wegovy reduced risk of adverse cardiovascular events by 20% in adults with obesity in trial
Novo Nordisk’s U.S.-listed stock NVODK:NOVO.B rose 10% premarket Tuesday, after the company said its obesity treatment semaglutide, marketed as Wegovy, met its main goal in a trial evaluating its ability to reduce cardiovascular events and not just help
Announcement as on 08 August 2023

Announcements by Novo Nordisk A/s first page | Next page | Prev page |

NVO Novo Nordisk A/s current price & indicator signals

Moving Averages for Novo Nordisk A/s

  • 5Day Average: 37.7
  • 12Day Average: 38.77
  • 20Day Average: 40.65
  • 50Day Average: 44.46
  • 100Day Average: 45.41
  • 150Day Average: 43.57
  • 200Day Average: 45.65

NVO Indicators & signals

Indicator MACD (12,26,9)

38.97, 41.13, -1.98
Indicator MACD is in negative zone

Indicator ADX (14)

50, 13.79, 41.38
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 47
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NVO Novo Nordisk A/s are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
05 Mon Oct 2026 37.56 36.46 to 37.76 0.64% 0.64 times
02 Fri Oct 2026 37.32 37.17 to 37.65 -0.24% 0.61 times
01 Thu Oct 2026 37.41 37.37 to 38.15 -1.32% 0.55 times
30 Wed Sep 2026 37.91 37.89 to 38.77 -1.04% 1.28 times
29 Tue Sep 2026 38.31 38.05 to 38.38 -1.03% 0.56 times
28 Mon Sep 2026 38.71 38.23 to 38.90 -0.21% 0.68 times
25 Fri Sep 2026 38.79 38.41 to 38.88 0.41% 0.45 times
24 Thu Sep 2026 38.63 37.61 to 38.72 1.21% 0.87 times
23 Wed Sep 2026 38.17 38.16 to 39.14 -3.12% 1.1 times
22 Tue Sep 2026 39.40 39.11 to 39.89 -1.05% 1.45 times
21 Mon Sep 2026 39.82 39.54 to 43.72 -7.91% 2.44 times
18 Fri Sep 2026 43.24 42.78 to 43.54 0.12% 0.62 times

Videos related to: NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

 

Back to top